Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding

Tissue Antigens

Volumn 73, Issue 6, 2009, Pages 599-603

  Ramos Lopez, E ^a   Scholten, F ^a   Aminkeng, F ^b   Wild, C ^c   Kalhes, H ^a   Seidl, C ^c   Tonn, T ^c   Van Der Auwera, B ^b   Badenhoop, K ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b DIABETES RESEARCH CENTER   (Belgium)

^c Institute of Transfusion Medicine and Immunohaematology   (Germany)

Author keywords

Killer cell immunoglobulin like receptor; Polymorphism; Type 1 diabetes

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2;

ALLELE; ARTICLE; BELGIUM; CHROMOSOME 19Q; CONTROLLED STUDY; CYTOTOXICITY; EXON; GENE CLUSTER; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIGAND BINDING; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE;

ALLELES; BELGIUM; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HAPLOTYPES; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, KIR2DL2;

EID: 65649085929     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01252.x     Document Type: Article

References (24)

1. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001 : 1 : 41 9. (Pubitemid 33741974)
2. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 2001 : 181 : 158 9. (Pubitemid 32703404)
3. Lanier LL. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 1998 : 92 : 705 7. (Pubitemid 28155309)
4. Lanier LL. Activating and inhibitory NK cell receptors. Adv Exp Med Biol 1998 : 452 : 13 8. (Pubitemid 28478079)
5. Moretta A, Bottino C, Vitale M et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996 : 14 : 619 48. (Pubitemid 26130196)
6. Moretta A, Vitale M, Sivori S, Morelli L, Pende D, Bottino C. Inhibitory and activatory receptors for HLA class I molecules in human natural killer cells. Chem Immunol 1996 : 64 : 77 87. (Pubitemid 26381709)
7. Moretta L, Mingari MC, Pende D, Bottino C, Biassoni R, Moretta A. The molecular basis of natural killer (NK) cell recognition and function. J Clin Immunol 1996 : 16 : 243 53. (Pubitemid 26338197)
8. Steffens U, Vyas Y, Dupont B, Selvakumar A. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR). Tissue Antigens 1998 : 51 : 398 413. (Pubitemid 28154491)
9. Gardiner CM. Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int J Immunogenet 2008 : 35 : 1 8.
10. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002 : 54 : 221 9.
11. Mogami S, Hasegawa G, Nakayama I et al. Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes. Tissue Antigens 2007 : 70 : 506 10. (Pubitemid 350075803)
12. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003 : 52 : 2639 42. (Pubitemid 37210556)
13. van der Slik AR, Alizadeh BZ, Koeleman BP, Roep BO, Giphart MJ. Modelling KIR-HLA genotype disparities in type 1 diabetes. Tissue Antigens 2007 : 69 : 101 5. (Pubitemid 46625865)
14. Nikitina-Zake L, Rajalingham R, Rumba I, Sanjeevi CB. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls. Ann N Y Acad Sci 2004 : 1037 : 161 9. (Pubitemid 40299761)
15. Santin I, de Nanclares GP, Calvo B, Gaafar A, Castano L, Bilbao JR. Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus. Hum Immunol 2006 : 67 : 118 24. (Pubitemid 43673913)
16. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997 : 7 : 753 63. (Pubitemid 28064889)
17. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002 : 169 : 5118 29. (Pubitemid 35217181)
18. Donner H, Seidl C, Van der AB et al. HLA-DRB1*04 and susceptibility to type 1 diabetes mellitus in a German/Belgian family and German case-control study. The Belgian Diabetes Registry. Tissue Antigens 2000 : 55 : 271 4. (Pubitemid 30150949)
19. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955 : 19 : 251 3.
20. Middleton D, Halfpenny I, Meenagh A, Williams F, Sivula J, Tuomilehto-Wolf E. Investigation of KIR gene frequencies in type 1 diabetes mellitus. Hum Immunol 2006 : 67 : 986 90.
21. Bradshaw D, Schammel CM, Posch P, Steiner NK, Hurley CK. Development of informatics tools for complex gene systems: killer-cell immunoglobulin-like receptor genes. Tissue Antigens 2003 : 61 : 118 35. (Pubitemid 36549598)
22. Schellekens J, Rozemuller EH, Petersen EJ, van den Tweel JG, Verdonck LF, Tilanus MG. Activating KIRs exert a crucial role on relapse and overall survival after HLA-identical sibling transplantation. Mol Immunol 2008 : 45 : 2255 61.
23. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol 2008 : 180 : 3969 79.
24. Mandelboim O, Kent S, Davis DM et al. Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells. Proc Natl Acad Sci U S A 1998 : 95 : 3798 803. (Pubitemid 28173209)